Comprehensive research into prognostic and immune signatures of transcription factor family in breast cancer.

Wu, Qing; Zheng, Shiyao; Lin, Nan; Xie, Xianhe

Wu, Qing; Zheng, Shiyao; Lin, Nan; Xie, Xianhe.

Affiliation

Wu Q; Department of Oncology, Molecule Oncology Research Institute, The First Affiliated Hospital of Fujian Medical University, No. 20 Chazhong Road, Fuzhou, 350005, Fujian, China.
Zheng S; Department of Oncology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, 350212, China.
Lin N; College of Clinical Medicine for Oncology, Fujian Medical University, Fuzhou, Fujian, China.
Xie X; Fuzong Clinical Medical College of Fujian Medical University, Fuzhou, Fujian, China.

BMC Med Genomics ; 16(1): 87, 2023 04 25.

Article in En | MEDLINE | ID: mdl-37098532

Subject(s)

Breast Neoplasms; Prognosis; Breast Neoplasms/drug therapy; Breast Neoplasms/genetics; Breast Neoplasms/metabolism; Breast Neoplasms/pathology; Transcription Factors/genetics; Transcription Factors/metabolism; Humans; Risk Factors; Genetic Predisposition to Disease; Antineoplastic Agents/therapeutic use

Key words

Breast cancer; Immune checkpoints; Prognostic signature; Transcription factor family; Tumor immune microenvironment

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: BMC Med Genomics Journal subject: GENETICA MEDICA Year: 2023 Document type: Article Affiliation country: China Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google